Alan Seth Krasner
CIK 1435775 · Chief Medical Officer · last filed 2023-10-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.49M
Companies
2
Total Filings
26
Lifetime Open-Market Net
-$332.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRNX | Chief Medical Officer | 43,210 | $34.47 | $1.49M | -$318.1K | 9 | 2023-10-19 |
| ALBIREO PHARMA, INC. (BIOD) Delisted | Chief Medical Officer | 37,530 | — | — | -$14.3K | 17 | 2014-12-23 |
Recent Filings · Page 3 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-02-10 | ALBIREO PHARMA, INC. (BIOD) Delisted | Exer (M) | +12,850 | $0 | EDGAR |
| 2010-12-16 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-17 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-11-12 | ALBIREO PHARMA, INC. (BIOD) Delisted | Exer (M) | +3,100 | $6.0K | EDGAR |
| 2008-12-16 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-29 | ALBIREO PHARMA, INC. (BIOD) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 21–26 of 26
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.